Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AD/PD 2021 | Prime time for Alzheimer’s disease research

Colin L. Masters • 11 Mar 2021
AD/PD 2021
Alzheimer’s Disease

Colin L. Masters, MD, Florey Institute of Neuroscience and Mental Health, Parkville, Australia, shares his message to young clinicians and researchers. Prof. Masters believes this is the best time to get involved with Alzheimer’s disease research. The diagnostic armamentarium is evolving, and the therapeutics strategies are progressing. This interview took place during the AD/PD™ 2021 conference.

More from Colin L. Masters

2:25
Better diagnostic methods and therapies for Alzheimer's disease
Colin L. Masters • 11 Mar 2021
3:03
Alzheimer's disease and β-Amyloid: new revelations
Colin L. Masters • 11 Mar 2021
1:10
Evidence supporting the Aβ pathway in Alzheimer's disease
Colin L. Masters • 11 Mar 2021
1:42
Blood and CSF biomarkers for Alzheimer’s disease
Colin L. Masters • 11 Mar 2021

Related Videos

5:46
The impact of hypertension on neurovascular function in neurodegenerative diseases
Costantino Iadecola • 6 Feb 2024
3:26
Should endovascular thrombectomy be used in patients with pre-morbid dementia?
Aravind Ganesh • 20 Feb 2024
5:09
Defining the neurovasculome: advances in brain health research
Costantino Iadecola • 6 Feb 2024
3:55
The impact of the neurovasculome on cognitive function in neurodegenerative diseases
Costantino Iadecola • 6 Feb 2024
The content of VJNeurology is intended for healthcare professionals